Clearwater International acted as sole financial adviser to Merz Pharma GmbH & Co. KGaA on the sale of 100% of the share capital of Merz Dental GmbH to Shofu Inc.
Merz Pharma is a privately held pharmaceutical company based in Frankfurt, Germany. The company is active in research, development and distribution of innovative products in the areas of aesthetic medicine and dermatology, as well as in the field of neurologically induced movement disorders. Merz Pharma employs over 2,700 staff worldwide and generated revenues of approximately €1bn in fiscal year 2013/14.
Merz Dental, headquartered in Lütjenburg, Germany, is a leading manufacturer of dental products such as prosthetic acrylics, artificial teeth and digital full dentures for dentists and dental technicians. The company provides innovative products and high quality materials “Made in Germany“ to customers in more than 30 countries.
Shofu was founded in 1922 in Kyoto, Japan. Listed on the Tokyo stock exchange, the company offers a complete range of products to dentists and dental technicians worldwide and has locations in the US, Germany, UK, Singapore, and China.
Clearwater International, led by partner Ralph Schmücking, advised Merz Pharma